Lipid‐Altering Efficacy and Safety of Simvastatin 80 mg/Day: Long‐Term Experience in a Large Group of Patients with Hypercholesterolemia

Background: Elevated levels of low‐density lipoprotein (LDL) cholesterol promote the development of atherosclerosis and coronary heart disease. Hypothesis: Simvastatin 80 mg/day will be more effective than simvastatin 40 mg/day at reducing LDL cholesterol and will be well tolerated. Methods: Two sim...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Cardiol
Main Authors: Ose, Leiv, Davidson, Michael H., Insull, William, Wu, Mei, Tate, Ann C., Melino, Michael R., Mercuri, Michele, Mitchel, Yale B., Stein, Evan A., Kastelein, Johannes J. P., Scott, Russell S., Hunninghake, Donald B., Campodonico, Santiago, Escobar, Ivan D., Stepanavage, Michael E., Schrott, Helmut G.
Formato: Artigo
Idioma:Inglês
Publicado em: Wiley Periodicals, Inc. 2009
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6654890/
https://ncbi.nlm.nih.gov/pubmed/10680028
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.4960230108
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados